Literature DB >> 34080560

Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.

A A Jones1, J N Park2, S T Allen2, K E Schneider2, B W Weir2, D Hunt3, S G Sherman2.   

Abstract

OBJECTIVE: To evaluate racial (Black/White) differences in overdose response training and take-home naloxone (THN) possession and administration among clients and nonclients of the Baltimore syringe service program (SSP).
METHODS: The study derived data from a cross-sectional survey of 263 (183 SSP clients, 80 nonclients) people who inject drugs (PWID). The study recruited SSP clients using targeted sampling and recruited nonclients through peer referral from April to November 2016.
RESULTS: In our sample, 61% of the participants were Black, 42% were between the ages of 18 and 44, and 70% were males. SSP clients, regardless of race, were more likely to have received overdose response training than Black nonclients (Black clients AOR: 3.85, 95% CI: 1.88, 7.92; White clients AOR: 2.73, 95% CI: 1.29, 5.75). The study found no significant differences in overdose response training between Black and White nonclients. SSP clients and White nonclients were more likely to possess THN than Black nonclients (Black clients: AOR: 4.21, 95% CI: 2.00, 8.87; White clients: AOR: 3.54, 95% CI: 1.56, 8.04; White nonclients AOR: 4.49, 95% CI: 1.50,13.47).
CONCLUSION: SSP clients were more likely to receive overdose response training than their nonclient peers who they referred to the study, illustrating the utility of SSPs in reaching PWID at high risk of overdose. We also observed that Black PWID, who did not access services at the SSP, were the least likely to possess THN, suggesting the need to employ outreach targeting Black PWID who do not access this central harm reduction intervention.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Race; Syringe services programs; THN; Take-home naloxone

Mesh:

Substances:

Year:  2021        PMID: 34080560      PMCID: PMC8565096          DOI: 10.1016/j.jsat.2021.108412

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  31 in total

1.  "We want a living solution": views of harm reduction programs in black US Communities.

Authors:  Michael H Eversman
Journal:  J Ethn Subst Abuse       Date:  2015       Impact factor: 1.507

2.  Does take-home naloxone reduce non-fatal overdose?

Authors:  Trevor Bennett; Katy Holloway; Sheila M Bird
Journal:  Lancet       Date:  2014-01-11       Impact factor: 79.321

3.  Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.

Authors:  Seonaid Nolan; Jane Buxton; Sabina Dobrer; Huiru Dong; Kanna Hayashi; M J Milloy; Thomas Kerr; Julio Montaner; Evan Wood
Journal:  Public Health Rep       Date:  2017-07-27       Impact factor: 2.792

4.  Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial.

Authors:  Michael Kidorf; Robert K Brooner; Jeannie-Marie Leoutsakos; Jessica Peirce
Journal:  Drug Alcohol Depend       Date:  2018-04-16       Impact factor: 4.492

5.  Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City.

Authors:  Kyle Hunter; Ju Nyeong Park; Sean T Allen; Patrick Chaulk; Taeko Frost; Brian W Weir; Susan G Sherman
Journal:  Int J Drug Policy       Date:  2018-04-13

Review 6.  Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.

Authors:  Rebecca McDonald; Nancy D Campbell; John Strang
Journal:  Drug Alcohol Depend       Date:  2017-05-25       Impact factor: 4.492

7.  Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade.

Authors:  Karin Tobin; Catie Clyde; Melissa Davey-Rothwell; Carl Latkin
Journal:  Int J Drug Policy       Date:  2018-07-31

8.  A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania.

Authors:  Gia Elise Barboza; Kate Angulski
Journal:  Int J Drug Policy       Date:  2020-03-19

9.  Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.

Authors:  Perrine Roux; Jean-Marie Le Gall; Marie Debrus; Camélia Protopopescu; Khadim Ndiaye; Baptiste Demoulin; Caroline Lions; Aurelie Haas; Marion Mora; Bruno Spire; Marie Suzan-Monti; Maria Patrizia Carrieri
Journal:  Addiction       Date:  2015-09-28       Impact factor: 6.526

10.  Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland.

Authors:  Renee M Gindi; Monique G Rucker; Christine E Serio-Chapman; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2009-05-22       Impact factor: 4.492

View more
  2 in total

1.  Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.

Authors:  Alexis V Rivera; Michelle L Nolan; Denise Paone; Sidney A Carrillo; Sarah L Braunstein
Journal:  Subst Abus       Date:  2022       Impact factor: 3.984

2.  Responding to a surge in overdose deaths: perspectives from US syringe services programs.

Authors:  Madeline C Frost; Elizabeth J Austin; Maria A Corcorran; Elsa S Briggs; Czarina N Behrends; Alexa M Juarez; Noah D Frank; Elise Healy; Stephanie M Prohaska; Paul A LaKosky; Shashi N Kapadia; David C Perlman; Bruce R Schackman; Don C Des Jarlais; Emily C Williams; Sara N Glick
Journal:  Harm Reduct J       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.